The Role of a New Syringe Filter in Harm Reduction: The Views of Active Injection Drug Users (notice n° 586983)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02120cam a2200229 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250121143352.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Milhet, Maitena |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | The Role of a New Syringe Filter in Harm Reduction: The Views of Active Injection Drug Users |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2017.<br/> |
500 ## - GENERAL NOTE | |
General note | 85 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Reducing the risks associated with drug injection is a core component of the Drug Harm Reduction Policy. In France, this strategy was implemented in the context of the AIDS epidemic in the 1980s. Unless appropriate hygienic precautions are taken, injecting drugs may cause infectious, bacterial or fungal diseases. French Health authorities promote the use of effective tools to help reduce the harm associated with drug injection. In this context, public authorities supported the evaluation of new drug injection paraphernalia. Two qualitative studies were carried out among injection drug users in order to assess the acceptability of new tools disseminated on an experimental basis. The main objective of the evaluation was to identify the criteria governing the adoption or rejection of injection paraphernalia. This paper focuses on the acceptability of a specific syringe filter which is a decisive tool to reduce the harm associated with drug injection. The results show that drug users accept or refuse to change their injecting behaviour depending on specific criteria not entirely associated with public health concerns. The information from these studies suggests that strategies designed to reduce the harm associated with drug injection must be based on these individual criteria and should provide personalized and long-lasting assistance. |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | harm reduction |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | intravenous substance abuse |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | drug use disorder |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | unsafe injecting behaviours |
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
Topical term or geographic name as entry element | injection drug users |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jauffret-Roustide, Marie |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Santé Publique | 29 | 3 | 2017-07-10 | p. 311-320 | 0995-3914 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-sante-publique-2017-3-page-311?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-sante-publique-2017-3-page-311?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux